Athersys, inc / new (ATHX)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities
Net loss

-15,644

-9,923

-12,015

-9,688

-12,956

-11,321

-9,740

6,933

-10,155

-13,100

-7,243

-6,267

-5,631

-7,127

-6,004

-6,956

4,750

3,592

-6,497

-1,035

-12,482

-6,554

-4,719

675

-11,484

-9,795

-5,614

-5,946

-9,388

-3,237

-3,449

-3,713

-4,336

-4,252

-2,341

-3,223

-3,930

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

190

190

167

157

184

282

197

190

186

176

177

167

164

134

114

66

68

66

65

66

70

88

90

93

89

89

86

86

85

84

81

80

75

76

75

67

60

Gain from forgiveness of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

190

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

1

183

-

-

-

-

Stock-based compensation

1,280

1,300

1,309

1,152

1,090

1,116

1,096

837

800

812

814

729

689

723

747

723

707

742

731

705

751

711

714

601

579

605

605

197

116

101

111

133

136

151

135

147

119

Stock–based patent license and settlement expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

236

55

11

703

76

0

0

607

Change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

0

0

0

-728

-1,132

-191

-294

2,174

-

-

-

5,605

-

-

-

4,124

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,971

6

-216

2,563

-

-

-

-

-

-

-

-

Amortization of premium on available-for-sale securities and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3

-14

-17

-24

Changes in operating assets and liabilities:
Change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

96

-575

-

-

-

275

Accounts receivable

-

-

-

-

-

-

-

-

173

-

177

-1,236

1,168

300

-350

-58

345

46

-2,067

-455

2,143

29

-50

-179

374

67

-123

103

-17

52

-266

305

-290

352

-195

54

-1,956

Prepaid expenses, deposits and other

279

134

-314

424

-1,101

-397

-271

2,141

-127

-

-

-

231

200

-318

583

-3

51

32

-46

-41

4

109

-12

-68

97

-44

34

7

-101

-26

-396

-57

305

221

33

-48

Accounts payable and accrued expenses

1,664

-

-

-18

1,210

-

-

4,275

1,992

-

-345

-1,692

1,022

1,648

-135

500

400

233

240

-91

-678

40

284

250

-239

694

-920

-471

501

922

-592

101

-233

64

22

521

376

Deferred revenue

-

-

-

-

-

-

-

-

-

-

0

0

503

-

0

0

-245

-9,755

0

-27

9,952

70

-19

-22

-40

-

-

-

-

-759

759

-1,789

-1,351

174

-1,212

-1,288

-1,338

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-5,380

-

-5,499

-6,470

7,322

-5,359

-3,681

-5,840

1,116

-6,134

-6,249

-6,131

-7,277

-4,514

-5,721

-6,436

-6,113

-

-

-

-

-

-

-

-

Net cash used in operating activities

-12,103

-10,153

-8,214

-11,444

-5,515

-4,566

-7,498

4,392

-5,678

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,614

-4,991

-5,417

-4,482

-4,161

-4,043

-1,803

Investing activities
Purchase of available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

6,008

6,500

Proceeds from maturities of available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,000

3,237

4,000

8,169

7,503

2,000

Purchases of equipment

347

145

34

336

64

163

620

457

292

117

32

2

134

76

1,132

317

186

33

26

10

63

27

78

42

150

54

58

172

101

40

70

31

206

25

188

315

62

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-134

-

-1,495

-10,520

-186

-33

-26

-10

-63

-27

-78

-42

-150

-54

-58

-172

-101

-

-

-

-

-

-

-

-

Net cash used in investing activities

-347

-145

-34

-336

-64

454

-620

-457

-292

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-70

969

3,031

3,975

7,981

1,180

-4,562

Financing activities
Proceeds from Issuance of Common Stock

10,250

-

-

-

5,607

-

-

-

-

-

6,593

2,393

20,877

1,642

1,512

450

424

-61

0

2,765

7,606

-

-

-

-

-

4,783

3,808

2,026

21,197

730

54

8,376

753

0

-45

11,887

Proceeds from issuance of common stock and warrants, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-80

-55

-58

19,814

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

1

0

0

1,861

-

-

-

-

0

0

0

976

0

0

0

938

-

-

-

-

-

-

-

-

-

-

-

-

Shares retained for withholding tax payments on stock-based awards

149

104

144

107

69

101

110

107

84

83

107

56

37

49

91

154

173

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of treasury stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

106

74

257

0

0

0

292

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

22,701

-

1,466

413

251

-114

-106

2,691

8,325

-80

-55

-58

20,460

18,702

4,696

4,160

2,026

-

-

-

-

-

-

-

-

Net cash provided by financing activities

10,101

4,893

4,457

4,999

5,538

7,204

2,732

-255

26,327

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

730

104

8,376

753

0

-45

11,887

Decrease in cash and cash equivalents

-2,349

-5,405

-3,791

-6,781

-41

3,092

-5,386

3,680

20,357

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-360

-3,346

17,187

6,444

-5,528

-16,577

7,387

-5,506

-3,813

-3,159

9,378

-6,241

-6,382

-6,231

13,033

14,134

-1,083

-2,448

-4,188

17,630

-2,954

-3,918

5,990

246

3,820

-2,908

5,522

Consolidated entity excluding, related party
Accounts receivable

0

2

-65

69

-251

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Healios
Accounts receivable

-686

-450

-1,513

441

-2,261

-2,524

-1,580

8,598

51

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue - Healios

0

-286

349

-1,171

499

1,114

-406

1,402

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Advances and deposits from Healios

0

-

333

-942

845

-

464

148

1,583

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock, net

-

-

-

-

-

148

0

-148

20,995

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Consolidated entity, excluding related party
Proceeds from issuance of common stock, net

-

-

-

-

-

7,157

2,842

0

5,416

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-